283
BOSTON — Tango Therapeutics, a biotechnology company that develops treatments for cancer patients, has signed a 65,000-square-foot office lease in the Fenway neighborhood of Boston. Tango will move its headquarters to 201 Brookline Avenue, a 500,000-square-foot, Class A lab and office building that is currently under construction and slated for completion later this year. Local developer Samuels & Associates owns the property. Jon Varholak, Eric Smith and McKenna Teague of CBRE represented Tango in the lease negotiations.